Innovent Announces IBI3003 (GPRC5D/BCMA/CD3 Trispecific Antibody) Receives Fast Track Designation from the U.S. FDA for Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Jan. 27, 2026 /PRNewswire/ — Innovent Biologics, Inc.…
Nearly One-Quarter of Japanese Consumers Are Considering Switching Internet Providers Citing Quality Issues as the Leading Factor, According to New Airties Survey
24% of Japanese consumers said they are considering changing their home Internet…
